EG21567A - Method of crystallizing a tetrahydropy ridine derivative and crystalline forms thereby obtained - Google Patents

Method of crystallizing a tetrahydropy ridine derivative and crystalline forms thereby obtained

Info

Publication number
EG21567A
EG21567A EG138397A EG138397A EG21567A EG 21567 A EG21567 A EG 21567A EG 138397 A EG138397 A EG 138397A EG 138397 A EG138397 A EG 138397A EG 21567 A EG21567 A EG 21567A
Authority
EG
Egypt
Prior art keywords
tetrahydropy
ridine
crystallizing
derivative
crystalline forms
Prior art date
Application number
EG138397A
Other languages
English (en)
Inventor
Antoine Caron
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of EG21567A publication Critical patent/EG21567A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG138397A 1996-12-23 1997-12-23 Method of crystallizing a tetrahydropy ridine derivative and crystalline forms thereby obtained EG21567A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615904A FR2757543B1 (fr) 1996-12-23 1996-12-23 Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Publications (1)

Publication Number Publication Date
EG21567A true EG21567A (en) 2001-12-31

Family

ID=9499043

Family Applications (1)

Application Number Title Priority Date Filing Date
EG138397A EG21567A (en) 1996-12-23 1997-12-23 Method of crystallizing a tetrahydropy ridine derivative and crystalline forms thereby obtained

Country Status (39)

Country Link
EP (1) EP0950050B1 (is)
JP (2) JP4499188B2 (is)
KR (1) KR100586670B1 (is)
CN (1) CN1129580C (is)
AR (1) AR009672A1 (is)
AT (1) ATE307802T1 (is)
AU (1) AU736697B2 (is)
BR (1) BR9714081A (is)
CA (1) CA2275596C (is)
CO (1) CO5070688A1 (is)
CZ (1) CZ296689B6 (is)
DE (1) DE69734460T2 (is)
DK (1) DK0950050T3 (is)
DZ (1) DZ2383A1 (is)
EE (1) EE04188B1 (is)
EG (1) EG21567A (is)
ES (1) ES2251038T3 (is)
FR (1) FR2757543B1 (is)
HK (1) HK1024002A1 (is)
HR (1) HRP970699B1 (is)
HU (1) HU227425B1 (is)
IL (1) IL129938A (is)
IN (1) IN186976B (is)
IS (1) IS2357B (is)
MY (1) MY118015A (is)
NO (1) NO312364B1 (is)
NZ (1) NZ336130A (is)
PL (1) PL190494B1 (is)
RS (1) RS49882B (is)
RU (1) RU2192416C2 (is)
SA (1) SA98180971B1 (is)
SI (1) SI0950050T1 (is)
SK (1) SK285088B6 (is)
TR (1) TR199901363T2 (is)
TW (1) TW518322B (is)
UA (1) UA60324C2 (is)
UY (1) UY24825A1 (is)
WO (1) WO1998028271A1 (is)
ZA (1) ZA9711576B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
FR2782082B3 (fr) * 1998-08-05 2000-09-22 Sanofi Sa Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
US9272068B2 (en) 2010-03-12 2016-03-01 Nippon Shokubai Co., Ltd. Process for producing water-absorbing resin
AP2013006779A0 (en) * 2011-04-15 2013-03-31 Emcure Pharmaceuticals Ltd An improved rilpivirine process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
CZ296689B6 (cs) 2006-05-17
EE9900264A (et) 2000-02-15
CO5070688A1 (es) 2001-08-28
AU5668498A (en) 1998-07-17
DE69734460T2 (de) 2006-07-06
RS49882B (sr) 2008-08-07
HRP970699B1 (en) 2007-03-31
YU28999A (sh) 2003-01-31
FR2757543B1 (fr) 1999-04-02
IS2357B (is) 2008-04-15
JP2001507012A (ja) 2001-05-29
EE04188B1 (et) 2003-12-15
TW518322B (en) 2003-01-21
IS5076A (is) 1999-06-10
DK0950050T3 (da) 2006-01-23
PL190494B1 (pl) 2005-12-30
CN1241180A (zh) 2000-01-12
NO993076D0 (no) 1999-06-22
KR20000069504A (ko) 2000-11-25
TR199901363T2 (xx) 1999-08-23
NZ336130A (en) 2001-01-26
SK82899A3 (en) 1999-12-10
SI0950050T1 (sl) 2006-04-30
FR2757543A1 (fr) 1998-06-26
UA60324C2 (uk) 2003-10-15
AR009672A1 (es) 2000-04-26
BR9714081A (pt) 2000-05-09
DE69734460D1 (de) 2005-12-01
HUP0001387A3 (en) 2002-03-28
CN1129580C (zh) 2003-12-03
CZ229299A3 (cs) 1999-09-15
ZA9711576B (en) 1998-06-25
HRP970699A2 (en) 1998-10-31
SK285088B6 (sk) 2006-06-01
AU736697B2 (en) 2001-08-02
NO993076L (no) 1999-06-22
SA98180971B1 (ar) 2006-09-13
HU227425B1 (en) 2011-05-30
EP0950050B1 (fr) 2005-10-26
MY118015A (en) 2004-08-30
IL129938A0 (en) 2000-02-29
CA2275596A1 (en) 1998-07-02
PL334256A1 (en) 2000-02-14
JP4499188B2 (ja) 2010-07-07
KR100586670B1 (ko) 2006-06-07
IN186976B (is) 2001-12-22
IL129938A (en) 2004-06-20
NO312364B1 (no) 2002-04-29
EP0950050A1 (fr) 1999-10-20
DZ2383A1 (fr) 2002-12-28
WO1998028271A1 (fr) 1998-07-02
CA2275596C (en) 2005-10-11
RU2192416C2 (ru) 2002-11-10
HUP0001387A2 (hu) 2000-09-28
ES2251038T3 (es) 2006-04-16
HK1024002A1 (en) 2000-09-29
ATE307802T1 (de) 2005-11-15
UY24825A1 (es) 1998-04-21
JP2009197022A (ja) 2009-09-03

Similar Documents

Publication Publication Date Title
PL332314A1 (en) Crystalline povoxyl cephditorene and method of obtaining same
HUP9904208A3 (en) Method for production of conducting element and conducting element
HK1023125A1 (en) Crystalline form of 4-Ä5-methyl-3-phenylisoxazol-4-ylÜbenzenesulfonamide
AUPO056296A0 (en) Bag and method of production
PL316778A1 (en) Method of obtaining nicotinic acid amide
PL313204A1 (en) Derivatives of piperidine, method of obtaining them
PL315055A1 (en) Crystalline derivatives of n-acetyloneuraminic acid and method of obtaining them
PL316897A1 (en) Method of obtaining hydroxylammonium salts
AU4143797A (en) A method of placing rail sections and a means therefore
PL326491A1 (en) Novel method of obtaining derivatives of phenylimidazolydine
HUT74163A (en) New crystalline cepheme-acid-addicional salts and process for producing them
EG21567A (en) Method of crystallizing a tetrahydropy ridine derivative and crystalline forms thereby obtained
PL333104A1 (en) Method of obtaining hydroxylammonia salts
HK1000886A1 (en) A method for production of 3-formyl-tetrahydrofuran
PL333414A1 (en) Multivalent salts of pyridostigmin and derivative compounds
GB9515445D0 (en) Dihydropyridine and pyridine derivatives and process for their preparation
AU2274797A (en) Crystalline protease and method for producing same
PL300317A1 (en) Method of obtaining indobufene in pharmaceutically advantageous crystalline form
AU697270C (en) Method of manufacturing crystalline microporous material
PL318306A1 (en) Method of obtaining crystalline cephuroxime ester
HUP9702472A3 (en) Process for producing allyl-amine derivative and salts thereof
AU2031895A (en) Method and apparatus for timing events
PL314646A1 (en) Novel benzimidasolic salts and method of obtaining them
AU3084197A (en) Bag and method of production
GB2296932B (en) Method of greenhouse insulation